Sumitomo Mitsui Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $875K | Sell |
4,601
-337
| -7% | -$57.9K | 0.02% | 101 |
|
|
2026
Q1 | $834K | Buy |
4,938
+37
| +0.8% | +$6.33K | 0.02% | 96 |
|
|
2025
Q4 | $827K | Sell |
4,901
-2,026
| -29% | -$329K | 0.01% | 93 |
|
|
2025
Q3 | $1M | Sell |
6,927
-570
| -8% | -$77.8K | 0.02% | 89 |
|
|
2025
Q2 | $948K | Buy |
7,497
+1,436
| +24% | +$176K | 0.02% | 92 |
|
|
2025
Q1 | $775K | Sell |
6,061
-637
| -10% | -$86.4K | 0.01% | 93 |
|
|
2024
Q4 | $886K | Sell |
6,698
-334
| -5% | -$47K | 0.01% | 97 |
|
|
2024
Q3 | $1.02M | Sell |
7,032
-507
| -7% | -$73.4K | 0.02% | 92 |
|
|
2024
Q2 | $1.03M | Sell |
7,539
-392
| -5% | -$52.3K | 0.03% | 92 |
|
|
2024
Q1 | $1.09M | Sell |
7,931
-1,366
| -15% | -$187K | 0.03% | 94 |
|
|
2023
Q4 | $1.26M | Sell |
9,297
-5,732
| -38% | -$699K | 0.04% | 87 |
|
|
2023
Q3 | $1.84M | Buy |
15,029
+289
| +2% | +$36.8K | 0.06% | 77 |
|
|
2023
Q2 | $1.87M | Sell |
14,740
-720
| -5% | -$93.5K | 0.06% | 79 |
|
|
2023
Q1 | $2M | Sell |
15,460
-84
| -0.5% | -$11K | 0.06% | 86 |
|
|
2022
Q4 | $2.04M | Sell |
15,544
-321
| -2% | -$41.5K | 0.08% | 82 |
|
|
2022
Q3 | $1.86M | Sell |
15,865
-3,600
| -18% | -$447K | 0.08% | 95 |
|
|
2022
Q2 | $2.29M | Sell |
19,465
-4,878
| -20% | -$579K | 0.06% | 101 |
|
|
2022
Q1 | $3.17M | Sell |
24,343
-1,110
| -4% | -$145K | 0.09% | 95 |
|
|
2021
Q4 | $3.88M | Buy |
25,453
+1,486
| +6% | +$230K | 0.11% | 78 |
|
|
2021
Q3 | $3.88M | Sell |
23,967
-990
| -4% | -$167K | 0.09% | 79 |
|
|
2021
Q2 | $4.08M | Buy |
24,957
+6,322
| +34% | +$974K | 0.09% | 70 |
|
|
2021
Q1 | $2.81M | Buy |
18,635
+3,620
| +24% | +$575K | 0.07% | 73 |
|
|
2020
Q4 | $2.27M | Sell |
15,015
-316
| -2% | -$45.2K | 0.06% | 73 |
|
|
2020
Q3 | $2.08M | Buy |
15,331
+6,431
| +72% | +$872K | 0.07% | 68 |
|
|
2020
Q2 | $1.22M | Buy |
8,900
+3,983
| +81% | +$508K | 0.04% | 70 |
|
|
2020
Q1 | $530K | Buy |
4,917
+198
| +4% | +$22.8K | 0.03% | 92 |
|
|
2019
Q4 | $569K | Buy |
4,719
+1,400
| +42% | +$156K | 0.04% | 82 |
|
|
2019
Q3 | $330K | Buy |
3,319
+612
| +23% | +$64.1K | 0.03% | 84 |
|
|
2019
Q2 | $295K | Sell |
2,707
-2,817
| -51% | -$300K | 0.02% | 86 |
|
|
2019
Q1 | $618K | Sell |
5,524
-5,124
| -48% | -$562K | 0.06% | 72 |
|
|
2018
Q4 | $1.01M | Sell |
10,648
-640
| -6% | -$67.9K | 0.06% | 59 |
|
|
2018
Q3 | $1.38M | Sell |
11,288
-3,874
| -26% | -$456K | 0.11% | 49 |
|
|
2018
Q2 | $1.67M | Sell |
15,162
-141
| -0.9% | -$15.1K | 0.17% | 41 |
|
|
2018
Q1 | $1.63M | Buy |
15,303
+11,994
| +362% | +$1.33M | 0.15% | 40 |
|
|
2017
Q4 | $353K | Buy |
+3,309
| New | +$354K | 0.05% | 58 |
|
Other funds holding IBB
CB
Sumitomo Mitsui Financial Group's IBB Position: Q2 2026 in Review
Sumitomo Mitsui Financial Group reduced its iShares Biotechnology ETF (IBB) stake by 6.8% in Q2 2026, selling an estimated $57.9K and leaving 4,601 shares worth $875K. The position accounts for 0.02% of the portfolio, ranked #101.
Sumitomo Mitsui Financial Group first reported a position in IBB in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.08M in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Sumitomo Mitsui Financial Group held 4,601 shares of iShares Biotechnology ETF worth $875K as of Q2 2026.
- Sumitomo Mitsui Financial Group sold 337 iShares Biotechnology ETF shares in Q2 2026, an estimated $57.9K.
- iShares Biotechnology ETF made up 0.02% of Sumitomo Mitsui Financial Group's portfolio in Q2 2026, its #101 holding.
- Sumitomo Mitsui Financial Group first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 35 quarters since.
- Sumitomo Mitsui Financial Group's iShares Biotechnology ETF position peaked at $4.08M in Q2 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.